|
Nov 2
|
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q3 2023 Earnings Call Transcript
|
|
Nov 2
|
Q3 2023 PROCEPT BioRobotics Corp Earnings Call
|
|
Sep 20
|
PROCEPT BioRobotics Announces New Corporate Headquarters in San Jose
|
|
Sep 12
|
PROCEPT BioRobotics® Receives U.S. FDA Investigational Device Exemption to Investigate Aquablation® Therapy for Prostate Cancer
|